480-883-7240
Our Medical Protocols are Unique
and Personalized to Your Needs.
and Personalized to Your Needs.
Our Doctors use a combination of traditional and alternative cancer therapies.
Cancer Types We Treat
If you can’t find the type of cancer you are interested in, please call our office. At Causenta, we treat most cancers and health conditions. It may just be that we haven’t updated our website because we are too busy taking care of our patients.
Learn More
Testicular Cancer
“The testicles are two glands that produce testosterone and sperm for reproduction purposes. This cancer is most commonly seen in males ages 15 to 35. Testicular tumors are named seminoma and non-seminoma. Non-seminomas will usually spread faster than seminomas.
The most common symptom of testicular cancer is swelling or a lump in the testicular area. It can also cause a dull ache in the groin or abdominal region, pain or discomfort in the testicle or scrotum, and back pain. This kind of cancer usually only affects one testicle and is usually very curable.”
For more information about testicular cancer, contact a helpful member of the Causenta team.
“There is no cookie cutter or one-size-fits-all approach at Causenta.”
Watch this 3-minute video to see how different our doctors’ treatment philosophy is.
Learn More about the latest Technologies you can find in Our cancer treatment center.
Articles
Videos
Podcast
ALL
Can’t find the cancer type you are looking for? Call our office today to speak to a cancer specialist
Ask us Anything or Request a 30-Minute Free Consultation
Hear Straight from Our Patients
*These are not paid endorsements
Marie's breast cancer recurrence led her to find a second family away from home at Causenta. Watch to see how her experience at Causenta differs from her first fight with breast cancer.
Find out how Causenta's cutting edge technologies and supplements are improving Devin's life after testicular cancer. -Devin
See what Diane has to say about Dr. Tom's approach and why she believes in her body's abilities now more than ever.
FOLLOW US
